Abstract:Acebutolol was successfully labeled with (125) I via direct electrophilic substitution reaction. Radioiodinated acebutolol was prepared with a maximum radiochemical yield of 96.5 ± 0.3% and in vitro stability up to 72 h. The in vivo biological distribution of radioiodinated acebutolol showed high heart uptake of 37.8 ± 0.14% injected activity/g organ with low lungs and liver uptakes at 5 min post-injection. In vivo receptor blocking study was carried out in mice to evaluate its selectivity to heart. Radioiodin… Show more
“…The indicated radionuclidic and radiochemical purity of I −131 product solution >99.9%, Figs. 7 and 8, are totally matching with the accepted criteria of pharmacopeia proving its safe use for human [37,38].…”
Purpose Oral administration of Iodine −131 (I −131) solutions causes high risk of contamination for patients and dispensers. The objective of the study was to adapt hard gelatin capsules (HGCs) for filling with radiopharmaceutical solutions without deformation. Methods Polystyrene (PS) internally lining films with different thicknesses were used to protect HGCs. The insulated HGCs were evaluated for their physicochemical characteristics and rupturing time in different dissolution media. HGCs internally lined with PS were examined for withstand loading with different volumes and radioactivities of I −131 solutions. Radioactivity release was studied in deionized water and acidic media. Quality control of released I −131 was inspected for radiochemical purities. Results There was a directly proportion between PS lining thickness and stability of HGCs after filling with 500 μl aqueous methylene blue solution. HGCs internally lined with PS 100 μm thickness withstand deformation for ˃ two months; however showed fast in-vitro rupturing time in different dissolution media. Internally lined HGCs loaded with different volumes and radioactivities of I −131 solutions resisted for one week without radioactive leakage. Yet, revealed complete release of I −131 after 20 min in dissolution media with great radiochemical purity. Conclusion The study promises safely I −131 aqueous solution delivery via adapted HGCs.
“…The indicated radionuclidic and radiochemical purity of I −131 product solution >99.9%, Figs. 7 and 8, are totally matching with the accepted criteria of pharmacopeia proving its safe use for human [37,38].…”
Purpose Oral administration of Iodine −131 (I −131) solutions causes high risk of contamination for patients and dispensers. The objective of the study was to adapt hard gelatin capsules (HGCs) for filling with radiopharmaceutical solutions without deformation. Methods Polystyrene (PS) internally lining films with different thicknesses were used to protect HGCs. The insulated HGCs were evaluated for their physicochemical characteristics and rupturing time in different dissolution media. HGCs internally lined with PS were examined for withstand loading with different volumes and radioactivities of I −131 solutions. Radioactivity release was studied in deionized water and acidic media. Quality control of released I −131 was inspected for radiochemical purities. Results There was a directly proportion between PS lining thickness and stability of HGCs after filling with 500 μl aqueous methylene blue solution. HGCs internally lined with PS 100 μm thickness withstand deformation for ˃ two months; however showed fast in-vitro rupturing time in different dissolution media. Internally lined HGCs loaded with different volumes and radioactivities of I −131 solutions resisted for one week without radioactive leakage. Yet, revealed complete release of I −131 after 20 min in dissolution media with great radiochemical purity. Conclusion The study promises safely I −131 aqueous solution delivery via adapted HGCs.
“…This leads to the DPP-4 suppression effect, blocking the inactivation of the incretin hormones with the consequent stimulation of insulin secretion and inhibition of glucagon secretion, leading to the control of the glucose level in the body. [75][76][77][78][79][80][81][82][83] In addition, it was clear that the excretion pathway of the 131 I-SQ compound is through the renal route. Moreover, it did not show any high accumulation in other body organs.…”
Section: In Vivo Pharmacokinetic Distribution Of the 131 I-sq Compoundmentioning
The current work represents the design and synthetic approaches of a new set of compounds 6–10 bearing the 1,4-dimethyl-2,3-dioxo-1,2,3,4-tetrahydroquinoxaline-6-sulfonamide scaffold.
“…The in vitro stability of 99m Tc-Mex-AuNPs was performed to evaluate its stability in physiological media, the feasibility of further in-vivo evaluations studies and confirming its suitability to be a physiologically stable nano-probe. 35 Exactly 100 ml of the 99m Tc-Mex-AuNPs was incubated with 900 ml of normal mice serum for 24 h at 37 °C.…”
Section: In Vitro Stability Of 99m Tc-mex-aunps In Mice Serummentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.